Retinitis Pigmentosa is an inherited condition that affects approximately 1 in 4,000 people worldwide. It typically begins in childhood or adolescence and progresses over time, often leading to significant vision impairment or blindness. While there is currently no cure for RP, early diagnosis and innovative treatments like stem cell therapy offer hope for slowing disease progression and preserving vision.

The symptoms of Retinitis Pigmentosa vary depending on the stage of the condition. Common signs include:

Night blindness: Difficulty seeing in low light or darkness.

Tunnel vision: Loss of peripheral vision, leading to a narrowed field of view.

Difficulty with color vision: Reduced ability to distinguish colors.

Slow adjustment to changes in light: Trouble transitioning from bright to dark environments.

Blurred vision: Gradual loss of central vision in advanced stages.

Photophobia: Sensitivity to bright light.

Retinitis Pigmentosa is caused by genetic mutations that affect the retina's ability to function properly. These mutations can be inherited in several ways:

Autosomal dominant: One affected parent can pass the condition to their child.

Autosomal recessive: Both parents must carry the gene for the child to be affected.

X-linked: The gene mutation is located on the X chromosome, affecting males more severely.

Sporadic cases: Occurs without a family history due to new genetic mutations.

Diagnosing Retinitis Pigmentosa involves a comprehensive eye examination and specialized tests, including:

Visual field testing: To assess peripheral vision loss.
Electroretinography (ERG): To measure the electrical activity of retinal cells.
Fundus examination: To examine the retina for characteristic changes, such as pigment deposits.
Optical coherence tomography (OCT): To visualize the retina's layers and detect abnormalities.
Genetic testing: To identify specific gene mutations associated with RP.

While there is no cure for Retinitis Pigmentosa, several treatment options can help manage symptoms and slow disease progression:

Low-vision aids:

Magnifying glasses, telescopic lenses, or electronic devices to assist with daily tasks.

Medications:

Vitamin A palmitate: Some studies suggest it may slow disease progression (under medical supervision).

Acetazolamide: To reduce swelling in the retina (macular edema).

Gene therapy:

Emerging treatments like voretigene neparvovec (Luxturna) for specific genetic mutations.

Retinal implants:

Devices like the Argus II retinal prosthesis to restore partial vision in advanced cases.

Advanced Stem Cell Treatments:

Stem cell therapy: At Concord Stem Cell Limited, we are exploring the potential of stem cells to regenerate damaged retinal cells, restore vision, and slow disease progression. Stem cell therapy offers hope for improving quality of life for RP patients.

Lifestyle adjustments:

Using sunglasses to protect against UV light.

Avoiding smoking and maintaining a healthy diet rich in antioxidants.

Why Choose Concord Stem Cell Limited?

As a DGDA-approved stem cell manufacturing and practicing company in Dhaka, Bangladesh, Concord Stem Cell Limited is at the forefront of innovative treatments for Retinitis Pigmentosa. Our team of experts combines advanced medical research with compassionate care to provide hope and improved outcomes for patients.

If you or a loved one is living with Retinitis Pigmentosa, contact us today to learn more about our cutting-edge treatment options, including stem cell therapy, and how we can support your journey to better vision and quality of life.